季度财报
Skye Bioscience(SKYE)05-11 04:05
$Skye Bioscience(SKYE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001516551-24-000055 Act: 34 Size: 4 MB 网页链接
简介:Skye Bioscience, Inc.于2011年3月16日在内华达州注册成立。该公司是一家临床阶段的生物制药公司,其使命是率先开发新药,释放ECS的制药潜力。他们的临床资产专注于CB1的调节,为代谢紊乱、炎症、纤维化和神经退行性变(如肥胖和青光眼)引起的疾病提供新的治疗方法和替代品。
今开:5.99 | 昨收:5.9 |
最高:6.22 | 最低:5.91 |
涨停价: | 跌停价: |
总市值:172898307 |
Skye Bioscience(SKYE)05-11 04:05
$Skye Bioscience(SKYE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001516551-24-000055 Act: 34 Size: 4 MB 网页链接
Skye Bioscience(SKYE)07-03 19:15
$Skye Bioscience(SKYE)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001516551-24-000064 Act: 34 Size: 180 KB 网页链接
Skye Bioscience(SKYE)05-11 04:25
$Skye Bioscience(SKYE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001628280-24-022632 Act: 33 Size: 1 MB 网页链接
Skye Bioscience(SKYE)05-18 04:35
$Skye Bioscience(SKYE)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001628280-24-024078 Act: 33 Size: 201 KB 网页链接
Skye Bioscience(SKYE)05-20 18:05
$Skye Bioscience(SKYE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001576 Act: 33 Size: 2 KB 网页链接
Skye Bioscience(SKYE)05-20 18:05
$Skye Bioscience(SKYE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001575 Act: 33 Size: 2 KB 网页链接
Skye Bioscience(SKYE)06-10 21:35
$Skye Bioscience(SKYE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001516551-24-000059 Act: 34 Size: 178 KB 网页链接
Skye Bioscience(SKYE)07-05 21:05
$Skye Bioscience(SKYE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001516551-24-000067 Size: 318 KB 网页链接
网络异常请稍后再试06-15 18:17
$Skye Bioscience(SKYE)$ CB1是人类中枢神经系统中表达量最高的G蛋白偶联受体(GPCR)之一,主要存在于大脑,在脾脏、肺、胸腺、心脏和血管中也有表达。由组织分布的多样性,CB1参与许多重要的生理病理过程,CB1作为疼痛、炎症、肥胖以及药物滥用等多个疾病领域药物的重要开发靶点。
Skye Bioscience(SKYE)07-05 21:05
$Skye Bioscience(SKYE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001516551-24-000068 Size: 5 KB 网页链接
网络异常请稍后再试06-15 18:17
$Skye Bioscience(SKYE)$ CB1是人类中枢神经系统中表达量最高的G蛋白偶联受体(GPCR)之一,主要存在于大脑,在脾脏、肺、胸腺、心脏和血管中也有表达。由组织分布的多样性,CB1参与许多重要的生理病理过程,CB1作为疼痛、炎症、肥胖以及药物滥用等多个疾病领域药物的重要开发靶点。查看全文
北美咨询网04-18 09:29
对于愿意及早介入的投资者来说,生物科技股有可能创造巨大的财富。然而,当药物试验出现意外时,生物科技股也可能一落千丈。这绝对不是一个适合胆小者投资的行业。找到合适的股票是关键。以下三只生物科技股最近报告了利好消息,股价大幅走高。今年以来,这三只生物科技股的股价已经飙升了至少269%...查看全文
漂洋过海后仰打铁2021-02-05 13:37
$SKYE BIOSCNC ORD(SKYE)$ 股票第一个评论!这个最近几天涨势喜人,这公司刚换的ceo,希望一两年步上正轨。期待一下查看全文
$Skye Bioscience(SKYE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001516551-24-000068 Size: 5 KB 网页链接
$Skye Bioscience(SKYE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001516551-24-000067 Size: 318 KB 网页链接
$Skye Bioscience(SKYE)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001516551-24-000064 Act: 34 Size: 180 KB 网页链接
$Skye Bioscience(SKYE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001516551-24-000059 Act: 34 Size: 178 KB 网页链接
$Skye Bioscience(SKYE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001576 Act: 33 Size: 2 KB 网页链接
$Skye Bioscience(SKYE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001575 Act: 33 Size: 2 KB 网页链接
$Skye Bioscience(SKYE)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001628280-24-024078 Act: 33 Size: 201 KB 网页链接
$Skye Bioscience(SKYE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001628280-24-022629 Act: 33 Size: 340 KB 网页链接
$Skye Bioscience(SKYE)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001628280-24-022632 Act: 33 Size: 1 MB 网页链接
$Skye Bioscience(SKYE)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001516551-24-000055 Act: 34 Size: 4 MB 网页链接